Liz Murrill

No public contact details available.

Open letters

Write to Liz

Be the first constituent to publish an open letter to this representative.

Key Figures

The Supreme Court rejects Louisiana's request for rehearing in Louisiana v. Callais on May 5, 2026, without comment, and simultaneously grants a request from the state to immediately finalize the opinion — bypassing the normal 25-day waiting period before judgment issues. The accelerated finalization allows Louisiana to begin drawing a new congressional map immediately rather than waiting until late May. Justice Samuel Alito includes a striking footnote noting the majority had wanted to issue the opinion nearly seven months earlier but was delayed by the dissenting justices. The immediate finalization leaves civil rights plaintiffs with no time to seek additional stays and effectively starts the clock for Louisiana's accelerated redistricting before its July 15 rescheduled primary.

Justice Samuel Alito, acting as the circuit justice for the Fifth Circuit, issues a temporary administrative stay on May 5, 2026, pausing the Fifth Circuit's ruling that had reinstated the in-person-only mifepristone requirement. The stay temporarily restores mail-order access to the abortion pill while the full Supreme Court considers whether to issue a longer-term injunction. Alito sets a May 11 deadline for Louisiana and the FDA to respond to emergency applications from Danco Laboratories and GenBioPro. The temporary stay is notable because Alito himself wrote the majority opinion in Dobbs v. Jackson overturning Roe v. Wade in 2022. Legal analysts note the stay does not necessarily reflect Alito's view of the merits but is standard practice to preserve the status quo pending full briefing.

Two Baton Rouge residents filed recall petitions against Louisiana Gov. Jeff Landry and AG Liz Murrill on May 4, 2026, after Landry suspended the state's U.S. House primary election to redraw congressional maps following the Supreme Court's Callais decision. Organizers need 500,884 signatures from registered voters across all 64 parishes within 180 days. Within two weeks, hundreds lined up at signing events from Shreveport to New Orleans, coordinated through volunteer networks with no major party backing.

In the days following the April 29, 2026 Callais ruling, multiple Southern states beyond Florida began preparing or executing congressional redistricting to eliminate majority-minority districts. Louisiana Governor Jeff Landry and Attorney General Liz Murrill suspended the state's May 16 primary to allow the legislature to draw a new compliant map. Legal analysts at the Brennan Center and NAACP Legal Defense Fund warned that the ruling would allow states to systematically reduce Black and Hispanic representation in Congress, with estimated losses of four to six minority-preferred House seats across the region.

The Fifth Circuit Court of Appeals rules on May 1, 2026, reinstating a nationwide requirement that mifepristone be obtained in person from a healthcare provider, effectively reversing the FDA's 2023 rule that allowed mail-order dispensing via telehealth. The ruling comes in a Louisiana lawsuit challenging the FDA's modification of the mifepristone REMS. Because the FDA rule applies federally, the Fifth Circuit's order blocks mail-order mifepristone in all 50 states — including states where abortion is legal — pending further court proceedings. Mifepristone manufacturers Danco Laboratories and GenBioPro ask Justice Samuel Alito to pause the ruling on an emergency basis. The ruling sets up a potential Supreme Court conflict between state abortion laws and federal drug approval authority.